Equitable Trust Co. boosted its stake in Azenta, Inc. (NASDAQ:AZTA – Get Rating) by 212.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 10,075 shares of the company's stock after buying an additional 6,851 shares during the period. Equitable Trust Co.'s holdings in Azenta were worth $432,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of AZTA. Kayne Anderson Rudnick Investment Management LLC purchased a new stake in Azenta during the second quarter worth about $300,687,000. William Blair Investment Management LLC purchased a new stake in shares of Azenta during the second quarter worth approximately $232,008,000. Artisan Partners Limited Partnership purchased a new stake in shares of Azenta during the second quarter worth approximately $221,422,000. Macquarie Group Ltd. purchased a new stake in shares of Azenta during the second quarter worth approximately $160,068,000. Finally, State Street Corp purchased a new stake in shares of Azenta during the second quarter worth approximately $141,290,000. 96.42% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on AZTA. TheStreet upgraded shares of Azenta from a "d+" rating to a "c-" rating in a research note on Tuesday, December 13th. KeyCorp lowered their price target on Azenta from $90.00 to $70.00 and set an "overweight" rating for the company in a report on Monday, October 24th. Needham & Company LLC increased their price objective on Azenta from $74.00 to $78.00 and gave the company a "buy" rating in a report on Tuesday, November 15th. Finally, Stephens increased their price objective on Azenta from $60.00 to $65.00 in a report on Thursday, November 17th. Four analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has a consensus rating of "Buy" and a consensus price target of $72.60.

Azenta Stock Performance

Azenta (NASDAQ:AZTA – Get Rating) last released its quarterly earnings data on Monday, November 14th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.10. The firm had revenue of $137.57 million during the quarter, compared to analysts' expectations of $132.01 million. Azenta had a return on equity of 1.31% and a net margin of 383.23%. On average, analysts predict that Azenta, Inc. will post 0.33 EPS for the current year.

About Azenta

(Get Rating)

Azenta, Inc is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services segments. The Life Sciences Products segment is involved in automated cold storage solutions for biological and chemical compound samples.

See Also

• Get a free copy of the StockNews.com research report on Azenta (AZTA)
• MarketBeat Week in Review – 1/16 – 1/20
• Does Old Dominion Show That Trucking Is Hitting The Brakes?
• Nordstrom Puts Fear Of Markdowns Into Retail Sector
• Exxon Mobil Stock: Within Striking Distance Of Buy Point
• High-Dividend-Yielding BHP Sees China Driving '23 Growth

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.